GlucoTrack (GCTK) Competitors $6.53 +0.22 (+3.49%) Closing price 07/2/2025 04:00 PM EasternExtended Trading$6.43 -0.10 (-1.47%) As of 04:43 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GCTK vs. IINN, PAVM, WOK, BTCY, SSKN, CODX, NURO, SINT, TNON, and POAIShould you be buying GlucoTrack stock or one of its competitors? The main competitors of GlucoTrack include Inspira Technologies OXY B.H.N. (IINN), PAVmed (PAVM), WORK Medical Technology Group (WOK), Biotricity (BTCY), Strata Skin Sciences (SSKN), Co-Diagnostics (CODX), NeuroMetrix (NURO), SINTX TECHNOLOGIES (SINT), Tenon Medical (TNON), and Predictive Oncology (POAI). These companies are all part of the "medical equipment" industry. GlucoTrack vs. Its Competitors Inspira Technologies OXY B.H.N. PAVmed WORK Medical Technology Group Biotricity Strata Skin Sciences Co-Diagnostics NeuroMetrix SINTX TECHNOLOGIES Tenon Medical Predictive Oncology Inspira Technologies OXY B.H.N. (NASDAQ:IINN) and GlucoTrack (NASDAQ:GCTK) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, media sentiment, valuation, earnings, analyst recommendations, profitability and dividends. Is IINN or GCTK more profitable? Company Net Margins Return on Equity Return on Assets Inspira Technologies OXY B.H.N.N/A N/A N/A GlucoTrack N/A N/A -544.87% Which has more risk & volatility, IINN or GCTK? Inspira Technologies OXY B.H.N. has a beta of 2.24, suggesting that its share price is 124% more volatile than the S&P 500. Comparatively, GlucoTrack has a beta of -0.24, suggesting that its share price is 124% less volatile than the S&P 500. Do analysts rate IINN or GCTK? Inspira Technologies OXY B.H.N. currently has a consensus price target of $2.00, suggesting a potential upside of 85.19%. Given Inspira Technologies OXY B.H.N.'s stronger consensus rating and higher possible upside, analysts clearly believe Inspira Technologies OXY B.H.N. is more favorable than GlucoTrack.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspira Technologies OXY B.H.N. 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00GlucoTrack 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has preferable valuation and earnings, IINN or GCTK? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInspira Technologies OXY B.H.N.N/AN/A-$11.05MN/AN/AGlucoTrackN/AN/A-$22.60M-$56.60-0.12 Do insiders and institutionals hold more shares of IINN or GCTK? 12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. Comparatively, 10.9% of GlucoTrack shares are owned by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are owned by insiders. Comparatively, 12.9% of GlucoTrack shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media prefer IINN or GCTK? In the previous week, Inspira Technologies OXY B.H.N. had 1 more articles in the media than GlucoTrack. MarketBeat recorded 3 mentions for Inspira Technologies OXY B.H.N. and 2 mentions for GlucoTrack. Inspira Technologies OXY B.H.N.'s average media sentiment score of 0.62 beat GlucoTrack's score of 0.33 indicating that Inspira Technologies OXY B.H.N. is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inspira Technologies OXY B.H.N. 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive GlucoTrack 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryInspira Technologies OXY B.H.N. beats GlucoTrack on 10 of the 10 factors compared between the two stocks. Get GlucoTrack News Delivered to You Automatically Sign up to receive the latest news and ratings for GCTK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GCTK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GCTK vs. The Competition Export to ExcelMetricGlucoTrackMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.02M$10.49B$5.54B$8.87BDividend YieldN/A2.09%5.39%4.10%P/E Ratio-0.1216.6626.1919.90Price / SalesN/A29.93414.04113.66Price / CashN/A22.7836.1356.90Price / Book-0.013.648.025.38Net Income-$22.60M$233.36M$3.15B$248.50M7 Day Performance25.10%1.00%1.48%2.06%1 Month Performance-23.89%3.01%3.67%4.86%1 Year Performance-99.69%-11.64%34.68%20.24% GlucoTrack Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GCTKGlucoTrack1.0609 of 5 stars$6.53+3.5%N/A-99.7%$3.02MN/A-0.125IINNInspira Technologies OXY B.H.N.2.8763 of 5 stars$0.81-4.3%$2.00+145.8%-22.3%$10.73MN/A0.0020News CoverageGap UpPAVMPAVmed4.7009 of 5 stars$0.62+2.6%$19.00+2,983.9%-16.8%$10.26M$2.99M0.8790Positive NewsWOKWORK Medical Technology GroupN/A$0.71+2.9%N/AN/A$10.07M$11.51M0.00226BTCYBiotricityN/A$0.40+7.6%N/A-48.7%$9.92M$12.06M-0.3740News CoverageGap DownSSKNStrata Skin Sciences3.2891 of 5 stars$2.38+3.9%$6.00+152.1%-14.6%$9.55M$33.56M-1.05120Gap DownCODXCo-Diagnostics4.4351 of 5 stars$0.28-0.8%$5.50+1,878.4%-76.7%$9.41M$3.91M-0.24100Gap UpNURONeuroMetrixN/A$4.55+4.4%N/A+26.4%$9.37M$3.03M-0.9920High Trading VolumeSINTSINTX TECHNOLOGIES2.5956 of 5 stars$3.19-0.9%$28.00+777.7%-26.0%$8.08M$2.89M-0.0640TNONTenon Medical2.126 of 5 stars$1.04+6.4%$4.67+348.7%+38.4%$7.42M$3.28M-0.048Positive NewsGap DownPOAIPredictive Oncology2.4131 of 5 stars$0.83+0.2%$3.00+260.6%-18.2%$7.41M$1.62M-0.2730News CoveragePositive News Related Companies and Tools Related Companies IINN Alternatives PAVM Alternatives WOK Alternatives BTCY Alternatives SSKN Alternatives CODX Alternatives NURO Alternatives SINT Alternatives TNON Alternatives POAI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GCTK) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GlucoTrack, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GlucoTrack With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GCTK Stock Alerts